Selling Business in Choppy Waters: How to Prepare During Regulatory or Political Uncertainty
- Dr Allen Nazeri DDS MBA
- Jun 20
- 4 min read
Selling business interests in today’s climate comes with more complexity than most owners are prepared for. In 2025, the convergence of geopolitical instability, tax reform fears, rising tariffs, and the Iran-Israel conflict has introduced a new level of unpredictability into the M&A landscape.
In this article, we explore how to approach selling business interests during volatile times—and how to prepare your company for a successful exit despite external chaos.
Selling Business in 2025: Why This Year Is Different
The macro conditions shaping 2025 make selling business interests more difficult, but also more urgent:
The Iran-Israel war continues to destabilize oil markets and elevate investor risk-aversion.
Rising U.S.-China tariffs have disrupted global supply chains and put pressure on healthcare inputs, medical device components, and logistics.
The U.S. election may bring dramatic tax reform, including potential hikes in capital gains rates.
Increased regulatory scrutiny, especially in healthcare (FTC crackdowns, CMS policy shifts), is slowing buyer approvals and adding compliance hurdles.
These forces don’t just impact valuation—they impact buyer confidence, due diligence timelines, and your ability to close.
Selling Business Smartly: De-Risk the Deal Before the Market Does
If you’re selling business assets in 2025, it’s critical to de-risk your transaction before the market does it for you. Buyers are looking for clean, well-prepared businesses that can withstand external pressure.
Ensure you have:
Clean financial statements (preferably reviewed or audited)
Resolved legal and tax liabilities
Transparent ownership structure
Transferable contracts and operational documentation
Post-close management continuity (even temporarily)
Deals are harder to finance during volatile periods. Your job is to reduce as many friction points as possible to increase speed and maintain valuation.
Selling Business With External Forces in Mind
Timing your exit isn't just about internal growth; it’s about understanding external risk.
When selling business interests in 2025, consider:
If your business depends on imported goods, tariffs may erode margins soon
If your revenue model relies on reimbursements, changing CMS regulations may lower valuation
If you’re eyeing capital gains advantages, a 2025 exit may preserve today’s lower tax rates before changes take effect in 2026
Waiting for certainty often leads to missed windows. Position your exit to ride through turbulence—not to wait for calm that may never come.
Selling Business Amid Geopolitical Conflict: Understanding the Ripple Effects
The Iran-Israel war may feel far away, but its impacts ripple globally:
Energy price fluctuations affect your logistics, utilities, and patient travel costs
Global investor pullback from emerging markets could reallocate capital away from M&A temporarily
Political focus on national security shifts attention (and budgets) away from non-essential healthcare rollups or growth deals
If you’re selling business assets tied to sectors sensitive to global sentiment (transportation, supply chain, discretionary medical spend), be prepared to show resilience through scenario planning and historical performance under pressure.
Selling Business in Uncertain Markets: Shape the Narrative or Lose Control
In times of uncertainty, buyers need more than numbers—they need confidence.
When selling business assets in today’s market, your Confidential Information Memorandum (CIM), pitch deck, and Zoom presentations should address:
How your business handled recent cost pressures
How dependent you are on international suppliers
What protections are in place against regulatory shifts
What cash runway or working capital support is needed post-close
Demonstrating your preparedness and adaptability can swing negotiations in your favor, especially when other sellers appear reactive or underprepared.
Conclusion: Selling Business Successfully Requires Urgency and Precision
If you're considering selling business interests in 2025, now is the time to act—not wait. Waiting for the world to stabilize might cost you more in valuation, tax, and time than any current uncertainty ever will.
The sellers who succeed this year are not just the best operators—they’re the most prepared negotiators. They:
Engage early
Align with experienced advisors
Present a resilient, compelling narrative
Move swiftly before conditions shift again
Need help navigating the process of selling business assets in today’s market? Let’s set up a quick strategy call to evaluate your options and protect your upside—even in choppy waters.
Dr. Allen Nazeri, aka "Dr. Allen," boasts over 30 years of global experience as a healthcare entrepreneur. He is the Managing Director at American Healthcare Capital and Managing Partner at PRIME exits. Dr. Allen provides strategic growth consulting to leadership teams of both privately held and publicly listed companies, ensuring their preparedness for successful exits.
He holds a Dental Degree from Creighton University and an MBA in M&A and Investment Banking from the University of Bedfordshire. Dr. Allen is the author of "Value Engineering: Strategies to 10X the Value of Your Clinic and Dominate the Market!" and the brand new book "Selling Your Healthcare Company at a Premium". Dr. Allen offers a free valuation to business owners ready for a partial or complete exit strategy. Dr. Allen collaborates with strategic buyers, private equity firms, and institutional investors, taking direct accountability for the annual successful sell-side representation of nearly $750M in enterprise value.
To have a confidential discussion about your company and receive a free valuation, please email Allen@ahcteam.com or Allen@ahcpexits.com
You can now communicate with Dr. Allen's clone https://www.delphi.ai/drallen
Kommentarer